tipo
- journal article
Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach
Documento
- Visão geral
- Identidade
- Informação adicional documento
- Outro
- Ver todos